Phio Pharmaceuticals Valuation
| PHIO Stock | USD 2.45 0.02 0.82% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Phio Pharmaceuticals Corp holds a recent Real Value of $19.73 per share. The prevailing price of the company is $2.45. Our model determines the value of Phio Pharmaceuticals Corp from analyzing the company fundamentals such as Shares Outstanding of 4.8 M, shares owned by institutions of 15.77 %, and Return On Equity of -0.76 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Phio Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Phio Pharmaceuticals Corp is based on 3 months time horizon. Increasing Phio Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Phio Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Phio Stock. However, Phio Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.45 | Real 19.73 | Hype 2.45 | Naive 2.63 |
The intrinsic value of Phio Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Phio Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Phio Pharmaceuticals Corp helps investors to forecast how Phio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Phio Pharmaceuticals more accurately as focusing exclusively on Phio Pharmaceuticals' fundamentals will not take into account other important factors: Phio Pharmaceuticals Total Value Analysis
Phio Pharmaceuticals Corp is at this time forecasted to have valuation of 3.3 M with market capitalization of 11.76 M, debt of 1.01 M, and cash on hands of 18.02 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Phio Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.3 M | 11.76 M | 1.01 M | 18.02 M |
Phio Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Phio is to check how much profit was generated for every dollar of assets it reports. Phio Pharmaceuticals holds a negative application of assets of -0.43 pct., losing $0.004343 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Phio Pharmaceuticals Corp shows how discouraging it operates for each dollar spent on its assets.Phio Pharmaceuticals Ownership Allocation
The market capitalization of Phio Pharmaceuticals Corp is $11.76 Million. Roughly 83.83 pct. of Phio Pharmaceuticals outstanding shares are held by general public with 0.4 % owned by insiders and only 15.77 (%) by third-party entities. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Phio Pharmaceuticals Profitability Analysis
Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (3.67 M).About Phio Pharmaceuticals Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Phio Pharmaceuticals Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Phio Pharmaceuticals Corp based exclusively on its fundamental and basic technical indicators. By analyzing Phio Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Phio Pharmaceuticals's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Phio Pharmaceuticals. We calculate exposure to Phio Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Phio Pharmaceuticals's related companies.Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts. Phio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Phio Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 7.9 M | |
| Forward Price Earnings | 0.3064 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.